Developmental regulation of α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex
- 5 May 2006
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 497 (1) , 61-77
- https://doi.org/10.1002/cne.20978
Abstract
This report is the second of a two‐part evaluation of developmental differences in α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid receptor (AMPAR) subunit expression in cell populations within white matter and cortex. In part I, we reported that, in rat, developmental expression of Ca2+‐permeable (GluR2‐lacking) AMPARs correlated at the regional and cellular level with increased susceptibility to hypoxia/ischemia (H/I), suggesting an age‐specific role of these receptors in the pathogenesis of brain injury. Part II examines the regional and cellular progression of AMPAR subunits in human white matter and cortex from midgestation through early childhood. Similarly to the case in the rodent, there is a direct correlation between selective vulnerability to H/I and expression of GluR2‐lacking AMPARs in human brain. For midgestational cases aged 20–24 postconceptional weeks (PCW) and for premature infants (25–37 PCW), we found that radial glia, premyelinating oligodendrocytes, and subplate neurons transiently expressed GluR2‐lacking AMPARs. Notably, prematurity represents a developmental window of selective vulnerability for white matter injury, such as periventricular leukomalacia (PVL). During term (38–42 PCW) and postterm neonatal (43–46 PCW) periods, age windows characterized by increased susceptibility to cortical injury and seizures, GluR2 expression was low in the neocortex, specifically on cortical pyramidal and nonpyramidal neurons. This study indicates that Ca2+‐permeable AMPAR blockade may represent an age‐specific therapeutic strategy for potential use in humans. Furthermore, these data help to validate specific rodent maturational stages as appropriate models for evaluation of H/I pathophysiology. J. Comp. Neurol. 497:61–77, 2006.Keywords
This publication has 104 references indexed in Scilit:
- Defining the nature of the cerebral abnormalities in the premature infant: a qualitative magnetic resonance imaging studyThe Journal of Pediatrics, 2003
- Glutamate receptor subunit 3 (GluR3) immunoreactivity delineates a subpopulation of parvalbumin-containing interneurons in the rat hippocampusJournal of Comparative Neurology, 2003
- Cortical radial glial cells in human fetuses: Depth‐correlated transformation into astrocytesJournal of Neurobiology, 2003
- The Changing Number of Cells in the Human Fetal Forebrain and its Subdivisions: A Stereological AnalysisCerebral Cortex, 2003
- CSF glutamate during hypoxia–ischemia in the immature ratDevelopmental Brain Research, 1999
- GluR2 Antisense Knockdown Produces Seizure Behavior and Hippocampal Neurodegeneration during a Critical WindowAnnals of the New York Academy of Sciences, 1999
- Developmental Changes Revealed by Immunohistochemical Markers in Human Cerebral CortexCerebral Cortex, 1996
- Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984Epilepsia, 1993
- Anatomical Features of the Developing Brain Implicated in Pathogenesis of Hypoxic‐Ischemic InjuryBrain Pathology, 1992
- Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral MicrodialysisJournal of Neurochemistry, 1984